Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Details for Australian Patent Application No. 2003268357 (hide)

Owner Schering Corporation Pharmacopeia Drug Discovery, Inc.

Inventors Park, Haengsoon; Dwyer, Michael P.; James, Ray Anthony; Doll, Ronald J.; Guzi, Timothy J.; He, Zhen Min; Girijavallabhan, Viyyoor Moopil; Paruch, Kamil; Tran, Vinh D.; Dillard, Lawrence W.

Agent Griffith Hack

Pub. Number AU-B-2003268357

PCT Number PCT/US03/27405

PCT Pub. Number WO2004/022559

Priority 60/408,030 04.09.02 US

Filing date 3 September 2003

Wipo publication date 29 March 2004

Acceptance publication date 3 May 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/408,030 04.09.02 US

13 May 2004 Application Open to Public Inspection

  Published as AU-B-2003268357

3 May 2007 Application Accepted

  Published as AU-B-2003268357

30 August 2007 Standard Patent Sealed

13 September 2007 Assignment Registered

  Pharmacopeia Drug Discovery, Inc.; Schering Corporation The patent has been assigned to Pharmacopeia, Inc.; Schering Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003268358-Method and apparatus for performing chemical reactions in a plurality of samples

2003268356-METHODS AND COMPOSITIONS FOR MODULATING XBP-1 ACTIVITY